XML 44 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
IPO
Private placement
Non-IPO Related Stock Transactions
Common Stock
Common Stock
IPO
Common Stock
Private placement
Common Stock
Non-IPO Related Stock Transactions
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Additional Paid-in Capital
Private placement
Additional Paid-in Capital
Non-IPO Related Stock Transactions
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2020         15,632,809                    
Balance at beginning of period at Dec. 31, 2020 $ (90,449)       $ 156       $ (1,846) $ 72,136       $ (333) $ (160,562)
Treasury stock, beginning balance (in shares) at Dec. 31, 2020                 (316,088)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon net settlement of restricted stock units and performance stock units (in shares)         414,896                    
Issuance of common stock upon net settlement of restricted stock units and performance stock units 18       $ 4         14          
Issuance of common stock, net of issuance costs (in shares)           5,750,000 1,562,500                
Issuance of common stock, net of issuance costs   $ 82,715 $ 24,250     $ 58 $ 16       $ 82,657 $ 24,234      
Conversion of convertible preferred stock into common stock upon IPO (in shares)         2,234,640                    
Conversion of convertible preferred stock into common stock upon IPO 35,754       $ 22         35,732          
Conversion of convertible notes (in shares)           3,636,189   33,978              
Conversion of convertible notes   58,179   $ 460   $ 36         58,143   $ 460    
Net exercise of warrants upon initial public offering (in shares)           844,335   130,529              
Net exercise of warrants upon initial public offering   $ 13,509   $ 861   $ 9   $ 2     $ 13,500   $ 859    
Fractional shares paid out related to the forward stock split (10)                 (10)          
Exercise of broker warrants (in shares)         47,188                    
Exercise of broker warrants 0                            
Exercise of stock options (in shares)         152,939                    
Exercise of stock options 980       $ 1         979          
Return of common stock to pay withholding taxes on restricted stock (in shares)                 (164,855)            
Return of common stock to pay withholding taxes on restricted stock (2,458)               $ (2,364) (94)          
Retirement of treasury stock (in shares)         (480,943)       (480,943)            
Retirement of treasury stock 0       $ (4)       $ 4,210 (4,206)          
Stock-based compensation 12,041                 12,041          
Foreign currency translation adjustment 230                         230  
Net loss $ (54,573)                           (54,573)
Balance at end of period (in shares) at Dec. 31, 2021 29,959,060       29,959,060                    
Balance at end of period at Dec. 31, 2021 $ 81,507       $ 300       $ 0 296,445       (103) (215,135)
Treasury stock, ending balance (in shares) at Dec. 31, 2021                 0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon net settlement of restricted stock units and performance stock units (in shares)         154,886                    
Issuance of common stock upon net settlement of restricted stock units and performance stock units (2)       $ 1         (3)          
Stock-based compensation 885                 885          
Foreign currency translation adjustment 189                         189  
Net loss $ (38,807)                           (38,807)
Balance at end of period (in shares) at Dec. 31, 2022 30,113,946       30,113,946                    
Balance at end of period at Dec. 31, 2022 $ 43,772       $ 301       $ 0 $ 297,327       $ 86 $ (253,942)
Treasury stock, ending balance (in shares) at Dec. 31, 2022                 0